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Post-septic encephalopathy is a poorly understood condition in survivors of sepsis that is characterised
by cognitive and affective impairments. In this study we have sought to better understand this condition
by undertaking a comprehensive behavioural and cognitive assessment of mice who had previously sur-
vived sepsis. Mice were treated with lipopolysaccharide (LPS; 5 mg/kg) and one month after this assessed
on a battery of tests. Post-septic animals were found to display significantly more immobility in the tail
suspension test and show a significantly decreased sucrose preference. Acute fluoxetine treatment
reversed the increase in immobility in the tail suspension test in post-septic animals. Post-septic animals
also showed less overall exploratory behaviour in the novel object recognition task and also showed
increased anxiety-like behaviour in the elevated plus maze. Post-septic mice did not show signs of cog-
nitive impairment, as assessed in the Morris watermaze, the 8-arm radial maze or on preference for the
novel object in the novel object recognition task. Immunohistochemical analysis revealed significant
upregulation of the microglial marker CD-11b, F4/80 and IBA-1 in the hippocampus of post-septic ani-
mals, as well as significant downregulation of the plasticity-related immediate early gene products
ARC and EGR1. We also observed a decrease in neural stem cell proliferation in the dentate gyrus of
post-septic animals as judged by BrdU incorporation. Co-treatment with the NF-jB pathway inhibitor
PDTC attenuated the long-lasting effects of LPS on most of the affected parameters, but not on neural
stem cell proliferation. These results show that LPS-induced sepsis in the mouse is followed by long-
lasting increases in depressive- and anxiety-like behaviours, as well as by changes in neuroinflammatory-
and neural plasticity-associated factors, and that attenuation of the severity of sepsis by PDTC attenuates
many of these effects.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Sepsis refers to a severe inflammatory response to infection
co-occurring with alterations in at least two of the following
parameters – body temperature, heart rate, respiratory rate and
white blood cell count (Robertson and Coopersmith, 2006). Septic
encephalopathy is a common complication of sepsis, occurring in
up to 70% of patients (Papadopoulous et al., 2000) involving a del-
eterious mental state ranging from confusion to coma (Jacob et al.,
2011). Structural and neuroinflammatory alterations persist in sur-
vivors, including reduced hippocampal volume and altered EEG
activity, leading to cognitive and psychological impairments for
years following recovery, and this condition is termed post-septic
encephalopathy (Lazosky et al., 2010; Iwashyna et al., 2010;Davydow et al., 2012; Semmler et al., 2013; Winters et al., 2010;
Ziaja, 2013). The aetiology of post-septic encephalopathy is not
well understood and there are currently no successful treatments
available.
While sepsis in humans is a heterogeneous condition, it is often
modelled in rodents using the intraperitoneal injection of a high
dose of the bacterial endotoxin lipopolysaccharide (LPS; Buras
et al., 2005; Doi et al., 2009). Peripheral administration of high-
dose LPS leads to a potent inflammatory response, via TLR-4
binding and subsequent NF-jB pathway activation. These LPS
treatments mimic many of the clinical features of sepsis and
results in a hyper-inflammatory response, accompanied by
depressed EEG rhythmicity, low blood pressure, oxidative stress,
multiple organ failure and a significant mortality rate (Chang
et al., 2013; Lin et al., 2010; Okazaki et al., 2014). Following recov-
ery from the acute effects of LPS-induced sepsis, an increased
level microglial activation persists in the CNS, accompanied by
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as time and dose dependent neuronal degeneration (Bossù et al.,
2012; Weberpals et al., 2009; Qin et al., 2007).
In addition to persistent neuroimmunological changes, there
have been a number of studies examining cognitive and affective
parameters following recovery from both LPS-induced, and cecal
ligation and puncture (CLP)-induced sepsis. There is considerable
variance in the behavioural changes present in post-septic animals
depending on both the method of sepsis induction and the latency
to test behaviour following recovery from sepsis. Within the
domain of learning and memory, post-septic animals have shown
cognitive impairments across tasks such as the step-down passive
avoidance task, the radial arm maze, and novel object recognition
tasks (Barichello et al., 2007; Cassol-Jr et al., 2010, 2011;
Semmler et al., 2007; Weberpals et al., 2009). Ten months after
LPS-induced sepsis rats show no differences in the elevated plus
maze or Morris watermaze, although they exhibit reduced explora-
tion and recognition of a novel object in the open field test (Bossù
et al., 2012). Sepsis survivor mice also show alterations in their cir-
cadian rhythms, and in their circadian responses to subsequent LPS
challenge (O’Callaghan et al., 2012; Anderson et al., 2013). Post-
septic animals have also been shown to display increased levels
of depressive-like behaviour including both anhedonia and behav-
ioural despair (Comim et al., 2010; Tuon et al., 2008) as well as
anxiety-like behaviour in the elevated plus maze ten days after
CLP (Calsavara et al., 2013). These affective changes may be linked
to the growing evidence for a neuroimmune basis to mood disor-
ders such as major depressive disorder (Berk et al., 2013; Miller
et al., 2009).
The aim of this study was to comprehensively characterize the
cognitive and affective state of sepsis-survivor mice one month
after LPS induced sepsis, as well as assessing changes in neuroim-
mune markers and neurogenesis in post-septic animals.2. Methods
2.1. Animals
For the purpose of all experiments male C57BL/6 mice (Charles
River, Kent, UK) aged between 8 and 16 weeks were used. Animals
were group housed in a 12:12 light:dark cycle for 2 weeks prior to
LPS administration. Food and water were available ad libitum
unless animals were on a food restriction protocol, temperature
was 21 ± 1 C and humidity was 50 ± 10%. Animals remained
housed in groups of 2–4 in polypropylene cages (33 cm
long  15 cm wide  13 cm high) with wood chip bedding and
environmental enrichment (shredded paper and cardboard tubes).
All procedures were approved by the Research Ethics Committee,
National University of Ireland Maynooth, and were licensed by
the Department of Health and Children, Ireland under statutory
instrument (S.I.) No. 543 of 2012 and the European directive
2010/63/EU.2.2. Drug treatments
All injections were prepared fresh on the treatment day, and
given intraperitoneally in a final injection volume of 0.1–0.15 ml.
0.9% sterile saline was made up fresh for control injections, while
lipopolysaccharide (serotype 0111.B4, Sigma Ireland; Qin et al.,
2007) was made up to a 5 mg/kg dose in sterile saline. PDTC (Sigma
Ireland) was administered in a 200 mg/kg dose (Liu et al., 1999)
10 min before LPS treatment while 20 mg/kg fluoxetine (Tocris
Bioscience, Bristol, UK) was administered 90 min before behav-
ioural testing. Mortality and significant moribundity requiring
euthanasia occurred in approximately 10% of animals followingthe induction of sepsis. Following sepsis induction animals were
individually assessed in terms of weight, activity in the homecage,
general appearance, behaviour and altered breathing at 1, 4, 24 and
48 h as well as at one week post LPS-administration. Animals were
scored between 0 and 5 on each parameter with scores then
totalled. To assess the number of neural precursor cells in the hip-
pocampus mice which had one month previously undergone sep-
sis-induction were injected i.p. with 50 mg/kg BrdU (Sigma
Ireland) and transcardially perfused 24 h later.
2.3. Behavioural experiments
Behavioural testing began one month after sepsis induction.
Each animal underwent no more than four tests, with less stressful
tests (open field, sucrose preference, etc.) preceding more stressful
tests (elevated plus maze, forced swim test, tail suspension test).
All animals only underwent one aversive test.
2.3.1. Marble burying task
As mice may bury novel objects which they find anxiety induc-
ing, the number of marbles buried during the test served as the
dependent measure of anxiety. Animals were placed in an isolated
testing arena (26 cm length  20 cm width  27 cm high) filled
with roughly 6 cm of wood chip bedding for 30 min with marbles
arranged in four rows of three, evenly spaced from each other and
the sides of the test cage (Deacon, 2006). After 30 min mice were
removed and marbles were considered buried where at least 2/3
of their surface was covered with woodchip. The dependent vari-
able from this test was the number of marbles buried.
2.3.2. Open field test
Open field testing occurred in an arena of diameter 100 cm.
Trial length was 300 s during which distance moved, velocity in
cm/s and time spent moving as well as time in the inner and outer
50% were automatically tracked with Ethovision 3.1 software
(Ethovision 3.1; Noldus Information Technology, Leesburg, VA).
Time spent in the inner corridor versus the outer corridor of the
arena is a measure of anxiety-like behaviour while distance, veloc-
ity and time spent moving are indexes of general locomotor
behaviour.
2.3.3. Hyponeophagia test
Measuring the time it takes for rodents to sample a novel food
in a novel situation is taken as a measure of anxiety-like behaviour.
Testing occurred in a large transparent plexiglass container (26
length  20 width  13.5 cm high) placed on a white surface using
existing methodology with chocolate as the novel food (Deacon,
2011). Animals were given up to 3 trials of 4 min, after which test-
ing for that animal stopped and they were given a score of 720 s if
they had not yet eaten.
2.3.4. Sucrose preference test
Preference for a sucrose solution over water functions as a
dependent measure of anhedonia Following a method set out in
Strekalova et al. (2004) bottles were filled with either animals’
standard drinking water or 1% sucrose in the animals standard
drinking water, lids securely taped in place to minimize spillage
and weighed. Cages were modified to accommodate two bottles,
and food was placed in both sides. Mice were then given a free
choice between either tap water, or a 1% sucrose in tap water solu-
tion for 24 h. After 12 h had passed, the position of the two bottles
was switched, in order to control for a side preference in drinking
behaviour. After 24 h had passed, the bottles were then weighed to
measure how much liquid was consumed, and sucrose preference
was calculated as [sucrose consumed/(water consumed + sucrose
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they were found to have liquid in their cages.
2.3.5. Forced swim test
This test measures depressive-like behaviour with immobility
taken as the dependent measure of behavioural despair. Animals
were placed singly in a 2 litre clear plexiglass beaker (12.5 cm
diameter  23.5 cm height) filled to a height of 12 cm with 1.25 l
water (25 C) such that their tails could not touch the bottom of
the beaker. Following the method of Porsolt et al. (1997) each test
lasted six minutes, with the immobility (absence of movement
except leg kicks to stay afloat) scored in the final four minutes only.
2.3.6. Tail suspension test
This is another test of behavioural despair. According to a pre-
viously used protocol (Steru et al., 1985) mice were attached to a
support raised to a height of 121 cm using tape placed 1 cm from
the tip of their tales for six minutes. Mice were suspended for six
minutes each, with immobility (complete absence of movement)
being recorded throughout the entire six minutes. For fluoxetine
treatments, on the experimental day 1 animals were injected with
0.9% sterile saline 90 min before undergoing the tail suspension
test. Two weeks later on experimental day 2 animals were injected
with 20 mg/kg fluoxetine dissolved in sterile saline 90 min prior to
repeating the test.
2.3.7. Novel object recognition test
Animals were first habituated to an arena of 50 cm. Each animal
underwent 5 trials lasting two minutes each. During the first four
trials, animals were habituated to two objects. Between each trial
the animal was removed while the objects and arena were cleaned
with 70% ethanol solution. On the fifth trial one familiar object was
replaced with a novel object. The objects had previously been
examined for preference with no differences being observed. These
objects were pseudo-randomized so that each object could func-
tion as either a familiar object or the novel object in any given ses-
sion. This randomization was balanced across each group. Animals
were measured on their time touching, and number of nose
touches for each object during each trial. This is typically a test
of working memory with novel object recognition, the dependent
variable, calculated as [time exploring the novel object/(time
exploring the novel object + time exploring the familiar object)]
or [number of touches on the novel object/(number of touches
on the novel object + number of touches on the familiar object)].
In this experiment time touching and number of touches on the
familiar and novel objects were also taken as measures of explor-
atory behaviour.
2.3.8. Working memory watermaze
Testing followed the protocol of Vorhees andWilliams (2006) in
a pool of diameter 100 cm, with water 21 ± 1 C. A rectangular
white card (55  81 cm) to the west of the pool was visible to
the mouse, and there were lights in the northeast and southeast.
Each animal underwent twenty-eight sixty-second trials over
seven sessions (4 trials/session). Two sessions took place per day
such that there was four hours between the first and second ses-
sion, then twenty hours between the second and third session
and so on. Each mouse was placed into the pool at the northeast,
northwest, southeast and southwest positions in a pseudo-random
order. In session one an invisible platform of diameter 9 cm was
submerged 0.5 cm below waterlevel in the northwestern quadrant
of the pool. This platform was moved clockwise from quadrant to
quadrant on each subsequent session. The mouse was returned
to a cage for 10 s between trials. Escape latency was defined as
the time it took the mouse to mount the hidden platform. All
experiments were tracked using a video camera and Ethovision3.1 software (Ethovision 3.1; Noldus Information Technology, Lees-
burg, VA). Escape latency, distance travelled and velocity (cm/s)
were measured throughout the trial. Escape latency was the pri-
mary dependent variable of interest functioning as a measure of
working memory. Savings was calculated as the difference in
escape latency between swim one and swim two.
Testing occurred in the same maze conditions previously
described in the section above. Each animal underwent 4 trials
per session for 6 sessions. Two sessions took place per day such
that there was four hours between the first and second session,
then twenty hours between the second and third session and so
on. Each mouse was placed into the pool at the northeast, north-
west, southeast and southwest positions in a pseudo-random
order. In all sessions an invisible platform of diameter 9 cm was
submerged 0.5 cm below water level in the North-Eastern quad-
rant of the pool. The mouse was returned to a cage for 10 s
between trials. Escape latency, distance travelled and velocity
(cm/s) were measured throughout the trials. Escape latency was
the primary dependent variable of interest functioning as a mea-
sure of spatial memory acquisition.
2.3.9. Radial 8-arm maze
This is a test of spatial working memory. Animals were placed
on an 80% restricted diet for five days before the first day of exper-
imental testing followed by a 60% restricted diet throughout the
duration of the experiment. The maze consisted of a centre area
of diameter 13.5 cm, from which 8 arms extended of length
34.5 cm, width 5 cm and height 13.5 cm. Similar to previously used
methodology (Janitzky et al., 2011), all eight arms of the maze
were baited with a food reward (chocolate). Trials were of five
minutes length, unless the animals successfully consumed all of
the bait. The apparatus was wiped down with 70% ethanol
between all trials to remove the previous animals’ odour. Each ani-
mal underwent one trial per day, for fourteen days. Entrances to an
arm were counted when all four of the mouse’s paws were within
the arm. The trial was ended once the animal either consumed all
rewards or once five minutes had passed. The primary dependent
variables were latency to complete the maze, a measure of learn-
ing, and the number of repeat entries to arms where bait was
already consumed, taken as a measure of working memory errors.
2.3.10. Elevated plus maze
This test assesses anxiety-like behaviour by measuring time
spent in the open arms and number of entries to the open arms
as primary dependent variables. The elevated plus maze was con-
ducted in accordance with the protocol set out by (Walf and Frye,
2007). The maze consisted of a centre area of diameter 13.5 cm,
from which four arms extended of length 34.5 cm, width 5 cm.
Two arms were open without walls, while the other two were
enclosed by high walls. Entrance to an arm was counted where
all four of an animals’ paws were within the arm. Animals under-
went one five-minute testing session each.
2.4. Immunohistochemistry
At least one week after their last behavioural task (so typically
2 months after the LPS treatment) mice were anaesthetized with
0.1 ml sodium pentobarbital (Euthatal, Merial Animal Health,
UK), following which they were perfused transcardially with 0.9%
saline, and then 4% paraformaldehyde (Sigma Ireland) in 0.1 M
phosphate buffer (PB), pH 7.4 at 4 C. Brains were then cryopro-
tected in 0.1 M PB containing 30% sucrose, frozen and sectioned
coronally at 30 lm. Immunohistochemistry followed a standard
Avidin–Biotin Complex/Nickel DAB colorimetric protocol (Beynon
et al., 2009). To control for inter-run variability all sections for indi-
vidual anti-bodies were reacted in the same run and developed for
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markers (CD11b, F4/80. IBA-1), astrocytes (GFAP), cytokines
(IL-1b, TNF-a, IL-6), iNOS, NF-jB pathway components (p-IKK,
p-IjB), IEGs (ARC, EGR1) and marker of cell proliferation (BrdU).
Details of the primary antibodies used can be found in Supplemen-
tal Table 1. Photomicrographs of sections were taken using a digital
camera connected to an Olympus BX-51 light microscope under
constant light intensity. Morphology and number of active microg-
lia stained with IBA-1 were assessed under 100 magnification
within a pre-defined area while for ARC the number of clearly
stained immunoreactive cells per area per section were counted
via microscope, and for all other antibodies image analysis soft-
ware (ImageJ 1.43, NIH, USA) was used to binarize and calculate
integrated optical density for each area of interest (Anderson
et al., 2013). For each method between 4 and 6 sections of the
mid dorso-ventral level of the hippocampus were analysed. Hippo-
campal sections were assessed across five areas of interest – the
dentate gyrus granule cell layer (DgGr), the dentate gyrus polymor-
phic cell layer (DgPo), CA1, CA2 and CA3, with the entire section of
interest analysed for each section (Franklin and Paxinos, 1997). For
BrdU immunohistochemistry the protocol was carried out as
above, but with an additional DNA denaturation step involving
incubation of sections in 1 M HCl for 30 min at 45 C (Wojtowicz
and Kee, 2006).2.5. Data analysis
All data values are given as mean ± SEM. Data was analysed in
IBM SPSS version 20. Inferential statistical analysis was via facto-
rial between groups or mixed between-within groups ANOVAs
and t tests as appropriate (paired or independent). P < 0.05 was
deemed statistically significant with appropriate Bonferroni cor-
rection applied for multiple comparisons.3. Results
3.1. LPS-induced sepsis induces depressive-like and anxiety-like
behaviours but no cognitive impairment
First we examined the performance of animals that had previ-
ously undergone sepsis or controls on a battery of behavioural
tests. On the sucrose preference test we found that post-septic ani-
mals showed significantly less preference for sucrose than controls
(preference ratio of 0.69 ± 0.04 in post-septic animals compared to
0.78 ± 0.02 in controls; independent t-test, t18 = 2.3, P < 0.05;
Fig. 1A). We found that post-septic animals showed no differences
in immobility in the forced swim test (Fig. 1B; independent t-test,
t30 = 0.68, P = 0.50) but did show significantly more immobility
on the tail suspension test (210 ± 9 s immobile for the post-septic
animals compared to 158 ± 10 s for control animals; independent
t-test, t29 = 3.95, P < 0.001, Fig. 1C). We next examined the effect
of acute fluoxetine treatment on immobility in the tail suspension
test in control and post-septic animals. We found that while fluox-
etine did not alter immobility levels in control animals (Fig. 1D), it
significantly reduced the amount of immobility in post-septic ani-
mals (2 way mixed between-within ANOVA indicates a significant
sepsis  fluoxetine interaction, F1,18 = 4.52, P < 0.05 and post hoc
analysis reveals that in the post-septic group fluoxetine treatment
significantly reduced immobility, t9 = 2.92, P < 0.05; Fig. 1E).
We then examined a cohort of animals on the elevated plus
maze, a commonly used test of anxiety-like behaviour in rodents.
We found that post-septic animals made significantly fewer entries
into the open arms than did the control animals (5.5 ± 0.9 entries
for the post-septic animals compared to 9.1 ± 0.9 entries for con-
trols; independent t-test, t22 = 2.79, P < 0.05; Fig. 2). Whenexamined in the open field test (S1), the marble burying task and
the hyponeophagia task (all tests of anxiety-related behaviour,
S2) there were no significant differences in performance detected
between the control and post-septic groups. Animals were then
tested on an object recognition task. This task can be used to assess
working memory as well as generalised exploration behaviour. In
terms of working memory we found no differences between the
control and post-septic animals in their exploration of the novel
object compared to the familiar object (Fig. 3A). However we found
that post-septic animals explored both the familiar and the novel
object significantly less than control animals (independent t-test,
t35 = 2.12, P < 0.05 and t35 = 2.51, P < 0.05 for time spent with famil-
iar and novel objects respectively, Fig. 3B and C).
Performance on a working memory version of the radial arm
maze was examined. Here we found that post-septic animals per-
formed as well as control animals on the parameters examined. For
example, using the number of arm entries until a previously-
entered arm is re-entered as a measure of working memory we
find a significant effect of time (mixed between-within subjects
ANOVA, F13,236 = 81, P < 0.001) but no main effect of treatment
(F1,22 = 0.41, P = 0.42) and no significant interaction between treat-
ment and time (F13,286 = 0.475, P = 0.97; Fig. 4A). Examining latency
to complete the task as the dependent variable, there was also a
main effect of time (F13,236 = 11, P < 0.001), but no main effect of
treatment (F1,22 = 0.41, P = 0.53) nor was there a significant interac-
tion between time and treatment (F13,286 = 0.46, P = 0.94; Fig. 4B).
We further examined both working and reference spatial memory
in control and post-septic animals using the Morris Water Maze.
Using the spatial working memory version of this task we did
not observe any differences in performance between control and
post-septic animals (Fig. 4C and D). Further, on the reference mem-
ory version of the task we did not find any significant differences in
acquisition between the post-septic animals and the control ani-
mals as assessed by escape latency across the 6 sessions of testing
(from mixed between-within subjects ANOVA there was a main
effect of time on escape latency F5,65 = 24.9, P < 0.001, but no effect
of treatment (F1,13 = 0.14, P = 0.74) or interaction between treat-
ment and time (F5,65 = 1.11, P = 0.36)). Therefore it appears that
the post-septic animals performed equally well on tests of working
and reference spatial memory/learning.
3.2. Long-lasting neuroimmune changes in post-septic mice
To examine neuroinflammatatory processes that may occur in
the post-septic brain we examined immunohistochemical staining
for a number of microglial markers in the hippocampus. We found
that levels of F4/80 and Cd-11b, and the number of IBA-1 express-
ing cells with a morphology associated with activated microglia,
were upregulated in the hippocampus of the post-septic animals
compared to controls (for example in the CA1 independent t-tests
show that t13 = 4.45, P < 0.01, t13 = 2.46, P < 0.05 and t6 = 2.46,
P < 0.05 for F4/80, Cd-11b and IBA-1 respectively; Fig. 5). There
were no changes in expression of the astrocytic marker GFAP in
the hippocampus, nor any observed changes in tumour necrosis
factor-a, interleukin-1b, inducible nitric oxide synthase, interleu-
kin-6, components of the NF-kB signalling pathway phosphory-
lated-IjB and phosphorylated-IKK (Supplementary Fig. 3).
Further immunohistochemical analysis was undertaken for mark-
ers of neural plasticity and neural stem cell progenitor prolifera-
tion. The number of cells in the subgranular zone of the dentate
gyrus that incorporated BrdU after a 24 h pulse was significantly
decreased in post-septic animals compared to controls (indepen-
dent t-test, t9 = 3.60, P < 0.01; Fig. 6A). The number of cells in the
dentate gyrus expressing the synaptic plasticity related immediate
early gene ARC was also significantly decreased in the post-septic
animals (independent t-test, t12 = 2.31, P < 0.05, Fig. 6B; ARC was
Fig. 1. Performance of post-septic animals on tests of depressive-like behaviour. (A) Performance on the sucrose preference test, a measure of anhedonia (N = 12 for control
and post-septic groups, ⁄ represent P < 0.05); (B) Performance on the forced swim test (N = 17 for controls, N = 15 for the post-septic group, no significant groupwise
difference); (C) Performance on the tail suspension test (N = 15 for control group and N = 16 for the post-septic group, ⁄⁄⁄ represents P < 0.001); (D) and (E) effects of acute
saline or fluoxetine treatment immobility in the tail suspension test in control and post-septic animals. Fluoxetine treatment attenuates the immobility in post-septic animals
(⁄ represents P < 0.05 between saline and fluoxetine treatments; N = 11 for controls and N = 10 for post-septic animals).
Fig. 2. Performance of control and post-septic animals on the elevated plus maze, a test of anxiety-like behaviour. Post-septic animals showed significantly fewer open arm
entries than controls (A; ⁄ represents P < 0.05) but there were no significant differences in time spent in the open arms (B), closed arm entries (C) or time spent in closed arms
(D). N = 13 for the control group and N = 11 for the post-septic group.
102 S.T. Anderson et al. / Brain, Behavior, and Immunity 43 (2015) 98–109not found to be expressed in other hippocampal subregions).
Expression of EGR1, another immediate early gene product associ-
ated with neural plasticity, was found to be significantly decreasedin the dentate gyrus and the CA1 of post-septic animals (indepen-
dent t-test, t6 = 4.3, P < 0.01 and t6 = 2.8, P < 0.05 for the DG and
CA1 respectively; Fig. 6C).
Fig. 3. Performance of control and post-septic animals on the novel object recognition test, a test of working memory and exploratory behaviour. The post-septic animals
showed a similar preference ratio for the novel object in the probe trial than the control animals (A). However post-septic animals explored both the familiar object (B) and
the novel object (C) significantly less. ⁄ represents P < 0.05, N = 20 for the control group and N = 18 for the post-septic group.
Fig. 4. Performance of control and post-septic animals on tests of spatial memory. (A) and (B) show performance on a working memory version of the 8-arm radial maze.
There was no groupwise difference between the control and post-septic groups as measured by the number of arm entries until a previously-entered arm is entered again (A)
or by the latency to complete the task and consume all eight pieces of food (B); N = 13 for the control group and N = 11 for the post-septic group. (C) and (D) show
performance on a working memory version of the Morris water maze. Again there was no differences in the escape latencies across the four trials (C) or in the time saving to
find the platform between swim one and swim two (D); N = 8 for the control group and N = 7 for the post-septic group. (E) Performance on the classical reference memory
version of the Morris water maze. There was no significant groupwise difference on this spatial memory task; N = 8 for controls and N = 7 for post-septic animals).
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associated with LPS-induced sepsis
We next undertook experiments in which we examined
whether the chronic effects described in post-septic animals could
be ameliorated by co-treatment with PDTC (an inhibitor of the NF-
jB pathway) at the time of LPS administration. We found that
PDTC treatment alone (at 200 mg/kg) induced an acute adverse
reaction (sedation, lack of responsiveness) but this effect resolved
within a number of hours (Fig. 7A). Co-treatment with LPS and
PDTC produced a less severe sepsis than produced with saline
and LPS. Three-way mixed between-within subjects ANOVA
(PDTC  LPS  Time) indicates significant main effects of time,
PDTC and LPS treatment (P < 0.01 for all), as well as Time  PDTC
and Time  LPS interactions (P < 0.001) and a Time  PDTC  LPS
interaction (P < 0.05). Therefore it appears that PDTC treatment
attenuates the sepsis clinical score induced by LPS. Animals were
later assessed on the behavioural tasks that had previouslyrevealed differences between the treatment groups. When ana-
lysed on the tail suspension test via between groups 2  2 factorial
ANOVA, there was a significant interaction between LPS and PDTC
treatment on time spent immobile (F1,37 = 9.1, P < 0.001; Fig. 7B).
Likewise when animals were examined on the elevated plus maze
there was a significant PDTC  LPS interaction (F1,37 = 6.21,
P < 0.05; Fig. 7C), and when they were examined for sucrose pref-
erence there was also a significant interaction between LPS and
PDTC treatments (F1,37 = 5.35, P < 0.05; Fig. 7D). When animals
were examined for time exploring both the novel and the familiar
object in the object recognition task there was a main effect of LPS
treatment on time spent with both objects (F1,37 = 11.1, P < 0.01;
Fig. 7E) but no main effect of PDTC treatment (P = 0.14) nor a sig-
nificant interaction between PDTC and LPS treatments on time
spent with both objects (P = 0.61).
Brains from animals treated with combinations of LPS/vehicle
and PDTC/vehicle were then analysed for BrdU, EGR1 and IBA-1
immunostaining (ARC was not examined due to technical
Fig. 5. Long-lasting upregulation of microglial markers in hippocampal subfields of post-septic animals. F4/80 (A), CD-11b (B) and IBA-1 were significantly upregulated
compared to controls 3–4 months after LPS-induced sepsis. N = 8 for controls and N = 7 for post-septic animals for both F4/80 and CD-11b, and N = 3–4 for both groups for
IBA-1. ⁄ represents P < 0.05, ⁄⁄ P < 0.01 and ⁄⁄⁄ P < 0.001. DG gr – granular cell layer of the dentate gyrus; DG po – polymorphic cell layer of the dentate gyrus. Scale bar in
photomicrographs = 100 lm.
Fig. 6. Long-lasting effects of sepsis on neural stem cell progenitor proliferation and on plasticity-related immediate early gene expression. (A) The number of cells in the
dentate gyrus incorporating BrdU after a 24 h pulse was significantly lower in post-septic animals than in controls. N = 5 for the control group and N = 6 for the post-septic
group, ⁄⁄ represents P < 0.01; (B) The expression of ARC in the dentate gyrus is significantly lower in post-septic animals. N = 8 for controls and N = 6 for the post-septic group,
⁄=P < 0.05. Data is shown only for the dentate gyrus as expression of ARC in other hippocampal subfields is negligible; (C) Expression of EGR1 is significantly lower in post-
septic animals than in controls in the dentate gyrus and the CA1. N = 4 for both groups, ⁄ represents P < 0.05, ⁄⁄ P < 0.01. The photomicrographs shows EGR1 expression in the
pyramidal cell layer of the CA1.
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Fig. 7. The NF-jB inhibitor PDTC attenuates the long-lasting effects of LSP-induced sepsis on behavioural parameters. (A) Co-treatment of animals with PDTC and LPS reduces
the severity of sepsis as assessed by animal welfare scores compared to those animals treated with saline and LPS. PDTC alone induces a short-lived adverse reaction. N = 10
for vehicle + vehicle, PDTC + vehicle, and vehicle + LPS groups, N = 9 for PDTC + LPS group. (B) PDTC treatment alters LPS-induced long-lasting effects in performance on the
tail suspension test (2 way ANOVA shows significant LPS  PDTC interaction, P < 0.001). (C) PDTC treatment impacts on LPS-induced effects on performance in the elevated
plus maze. There was a significant interaction between LPS and PDTC treatment on subsequent time spent in the open arms (P < 0.05); (D) PDTC treatment impacts on
LPS-induced changes in subsequent sucrose preference. There was a significant interaction between PDTC and LPS treatments on sucrose preference (P < 0.05); (E) Effect of
PDTC treatment on LPS-induced subsequent performance changes in exploration during the novel object recognition task. Although there appeared to be an amelioration of
LPS-induced decreases in object exploration in animals also treated with PDTC, there was not a significant LPS  PDTC treatment effect (P > 0.05).
Fig. 8. Effect of PDTC co-treatment on LPS-induced effects on BrdU incorporation, ARC and IBA-1 expression in the hippocampus. (A) PDTC treatment was not found to have a
significant interaction with LPS treatment on BrdU incorporating cells in the dentate gyrus (P > 0.05; N = 10 for each group); (B) PDTC does attenuate LPS-induced changes in
EGR1 expression in the long-term, with there being significant LPS  PDTC interactions (P < 0.05) in the DG, CA1 and CA3; (C) Effect of PDTC co-treatment on LPS-induced
changes on subsequent IBA-1 expression. There were significant interactions between LPS and PDTC treatment in the CA1 and the CA3.
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main effect of LPS treatment (2  2 ANOVA; F1,37 = 7.2, P < 0.05;
Fig. 8A) but no main effect of PDTC treatment (P = 0.079) and nointeraction between LPS and PDTC treatment (P = 0.51). When
EGR1 immunostaining was examined there were significant effects
of PDTC treatments on LPS-induced changes in the dentate gyrus,
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main effect of LPS treatment (F1,37 = 26.2, P < 0.001) and an interac-
tion between LPS and PDTC treatment (F1,37 = 6.5, P < 0.05).
Post-hoc pairwise analysis reveals that in the DG, CA1 and CA3 that
the levels of EGR1 in animals treated with LPS and saline are signif-
icantly lower than those treated with LPS and PDTC. When IBA-1
immunostaining was examined by two-way ANOVA, there were
significant main effects for LPS (F1,37 = 24.5, P < 0.001), PDTC
(F1,37 = 22.6, P < 0.001) and an interaction between LPS and PDTC
treatment (F1,37 = 22.1, P < 0.001) in the CA1. In the CA3 there were
also main effects of LPS (F1,37 = 6.1, P < 0.05) and PDTC (F1,37 = 6.4,
P < 0.05) and an interaction between LPS and PDTC treatment
(F1,37 = 9.9, P < 0.01). In both the CA1 and the CA3 the level of
IBA-1 immunostaining in animals treated with both LPS and PDTC
was significantly lower than in those animals treated with LPS and
saline.4. Discussion
4.1. Persistent depressive-like and anxiety-like behaviours
in sepsis-survivor mice
This study provides a comprehensive examination of the long-
lasting effects of LPS-induced sepsis on cognitive, behavioural
and neuroimmunological parameters in mice. While several stud-
ies have examined sickness behaviour in mice following low dose
treatment with LPS, there has been relatively little investigation
into the longer-term effects of LPS-induced sepsis. Sepsis-survivor
animals exhibited normal movement during open field and water-
maze testing indicating no gross impairment to motor skills or
locomotion. While post-septic encephalopathy in humans is char-
acterized by both cognitive and affective impairment (Ziaja, 2013),
in our study we found that post-septic mice had altered affective
behaviours only, with cognitive performance remaining intact in
the domains examined. This is in contrast to previous research
which has found impaired reference and working memory in the
radial arm maze following LPS-induced sepsis (Weberpals et al.,
2009), although cognitive impairment in the watermaze present
after seven consecutive doses of 5 mg/kg LPS was recovered
30 days after treatment in another study (Bian et al., 2013). There
are some methodological differences between how the 8-arm
radial maze task was run in our study compared to that used by
Weberpals et al. (2009) – for example differences in number of
arms baited and testing at different phases of the light/dark cycle.
Sepsis induced via CLP also seems to lead to impairments in learn-
ing and memory ten days post-treatment (Barichello et al., 2005,
2007; Comim et al., 2013), and importantly partial recovery of
function is present by 30 days and full cognitive recovery after
60 days (Tuon et al., 2008). There is of course the potential for
long-lasting sequela of LPS-induced sepsis to vary from those asso-
ciated with polymicrobial sepsis following CLP, and the severity of
sepsis will be increased in CLP models compared to the more mod-
erate LPS-induced sepsis examined here.
In addition to increases in depressive-like behaviours, post-
septic animals also exhibited heightened anxiety in the elevated
plus maze. Animals surviving CLP-induced sepsis show similarly
increased anxiety in the elevated plus maze at 10 days (Calsavara
et al., 2012), and somatic anxious (and depressive) symptoms have
been shown to be associated with elevated levels of inflammatory
factors in among healthy adults (Pitsavos et al., 2006; Hoge et al.,
2009). Although no memory impairment, measured by preference
percentage, was present in the novel object recognition task, sep-
sis-survivor mice did in fact show reduced overall exploration
when a novel object was introduced as compared with controls.
It has been suggested that LPS-induced reduction in objectexploration may be a function of lower motivation as well as/in
place of cognitive impairment (Haba et al., 2012). It seems likely
a reduction in motivation may be present in this model given the
other affective changes present in post-septic animals. Sepsis sur-
vivors experience high levels of psychosocial and emotional diffi-
culties years after recovering from sepsis itself (Lazosky et al.,
2010); for example, 6 months after ICU discharge 56% of sepsis sur-
vivors reported being either moderately or extremely anxious or
depressed (Orwelius et al., 2013) and have significantly lower
mental health and role-emotional SF-36 scores than the general
population (Hofhuis et al., 2008). In our model, increased depres-
sive-like behaviour was present in both the tail suspension test
and the sucrose preference test following recovery from sepsis,
mirroring some of the long lasting affective changes seen in other
sepsis models (Cassol-Jr et al., 2010; Comim et al., 2010). The lack
of effect in the forced swim test may reflect the different neural
mechanism postulated to regulate performance on the forced
swim and tail suspension tests (Cryan et al., 2005).
These results add to a wealth of existing literature on the rela-
tionship between inflammation and depressive symptoms both in
humans (Dowlati et al., 2010; Mössner et al., 2007) and animals
(Wang et al., 2011; You et al., 2011). Both acute (Frenois et al.,
2007) and chronic administration of LPS have been shown to pro-
duce depressive-like behaviours in mice (Kubera et al., 2013).
Importantly, as Wang et al. (2011) and Kubera et al. (2013) showed
that depressive behaviour induced by LPS administration could be
ameliorated upon fluoxetine administration, we have also shown
that an acute treatment with 20 mg/kg fluoxetine significantly
decreases time spent immobile in sepsis-survivor mice. This result
indicates that the post-septic model for examining affective
changes may have acceptable predictive validity, although further
experiments will be required to confirm this (eg. does chronic flu-
oxetine treatment attenuate anhedonia in post-septic mice). The
mechanism by which fluoxetine exerted its antidepressive effects
in sepsis-survivor mice is currently unknown, although fluoxetine
has previously been shown to exert neuroprotective (Chung et al.,
2010; Zhang et al., 2012) and anti-inflammatory (Liu et al., 2011)
effects in the presence of LPS stimulated microglia, as well as to
significantly reduce mortality upon the i.p. administration of LPS
in the lethal range (15–30 mg/kg; Su et al., 2012).
4.2. Alterations in neuroimmune parameters
In addition to behavioural alterations present after recovery
from sepsis, significant neuroimmune changes also occur within
the hippocampus of post-septic animals. Primarily, we note a
long-lasting activation of microglia, but not astrocytes, and altera-
tions in the expression of EGR1 and ARC. We also observe reduced
hippocampal NPCs in post-septic animals. Of note, at 2 months
post-treatment there were no differences between post-septic
mice and controls in hippocampal levels of IL-6, TNF-a or IL-1b.
This is at odds with a number of studies reporting an upregulation
of pro-inflammatory cytokines months after LPS-induced sepsis
(Bossù et al., 2012; Qin et al., 2007). However these current find-
ings are in agreement with Fan et al. (2012) and Weberpals et al.
(2009) who report sustained microglial activation in the absence
of astrocytic activation or heightened expression of cytokines
TNF-a or IL-1b in the hippocampus one week and two months fol-
lowing LPS-induced sepsis respectively, and are also in agreement
with our previous examination of changes in the circadian system
following sepsis (O’Callaghan et al., 2012). Therefore, the behav-
ioural alterations present in sepsis-survivor mice do not seem to
be the product of an over-expression of inflammatory cytokines
in the hippocampus, although this may be occurring in other brain
regions. Memory deficits following 10 mg/kg doses of LPS in rats
have been attributed to a significant reduction in the density of
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5 mg/kg dose of LPS in mice has been shown to only induce neuro-
degeneration 7 months after treatment (Qin et al., 2007).
Aside from inflammatory changes we also report a reduction in
levels of ARC and EGR1, both regulators of importance in neural
plasticity and memory (Bozon et al., 2003; Soulé et al., 2008). Both
antigens have also been used as markers of neuronal activity and
their transcription has previously been shown to be altered by var-
ious forms of LPS administration with differential expression
occurring based on animals’ age, activity prior to measurement,
time of measurement and other factors (Bonow et al., 2009; Rosi,
2011; Rosi et al., 2005). We also note a decrease in the number
of proliferating cells within the subgranular zone of the dentate
gyrus following sepsis in this model. Acute and chronic treatments
with LPS have previously been shown to reduce hippocampal neu-
rogenesis in the rodent hippocampus by reducing both cell prolif-
eration (Fukioka and Akema, 2010; Wu et al., 2013) and the
survival of newborn cells (Bastos et al., 2008; Ekdahl et al.,
2003). Indeed, an inverse correlation has been observed between
the number of microglia present within the hippocampus and
NPC proliferation (Gebara et al., 2013). Neurogenesis is strongly
implicated in the pathology of affective disorders, although the
experimental interruption of neurogenesis in the rodent hippo-
campus is not by itself always sufficient to produce increased anx-
iety-like and depressive-like symptoms, with stress appearing to
play an important role (Petrik et al., 2012). As we examined BrdU
expression after only 24 h it is unknown whether LPS-induced
sepsis affected the survival and differentiation of NPCs or their
integration into existing hippocampal networks and future work
will need to address such issues.4.3. Pre-treatment with PDTC attenuates LPS-induced long-lasting
effects
Pre-treatment with PDTC significantly attenuated the effects of
LPS treatment on behavioural and neuroimmune parameters in
this model. PDTC has previously shown to inhibit LPS induced IjBa
degradation which prevents the translocation of NF-jB dimers to
the nucleus and subsequent pro-inflammatory gene transcription
(Liu et al., 1999). It has been shown both to improve survival rate
and attenuate pro-inflammatory cytokine and iNOS levels follow-
ing septic doses of LPS (Lauzurica et al., 1999; Meisner et al.,
2000; Németh et al., 1998). It should be noted that while numerous
studies have used the 200 mg/kg i.p. dose of PDTC and reported no
adverse reactions, the acute reaction to PDTC treatment observed
in our study is congruent with a report of nervous system toxicity
of PDTC (Chabicovsky et al., 2010). However, we did not observe
any long term impairments or alterations in the animals treated
with PDTC alone in any measure examined, and are confident that
the adverse reactions observed were acute and did not elicit
longer-term consequences. PDTC reduced the severity of sepsis
induced by LPS and attenuated long-term LPS-induced increases
in depressive-like and anxiety-like behaviours. PDTC co-treatment
with LPS also lessened LPS-induced long-lasting changes in
microglial activation and EGR1 expression to levels similar to con-
trols. PDTC treatment however did not appear to rescue the reduc-
tion of NPCs in the hippocampus in LPS treated mice; this finding
may be due to the magnitude of sepsis attenuation not being suf-
ficient to significantly impact on the NPC proliferation. While PDTC
has not previously been shown to protect against LPS-induced cog-
nitive or affective impairment, it has been shown to protect against
cognitive impairment and anxiety-like behaviours in other models
involving inflammatory components such as acute restraint stress
(Sharma et al., 2011) and neonatal hypoxia–ischemia (Wang et al.,
2013).The current study comprehensively describes the long-lasting
behavioural and neuroimmune alterations present in mice follow-
ing LPS-induced sepsis, although the precise mechanisms through
which these changes occur are still unknown. Intact neuron-astro-
cyte-microglial signalling is essential for normal neuronal circuit
structure and homeostasis (Cerbai et al., 2012; Wake et al., 2013)
which may be compromised in this model given the elevated levels
of activated microglia. Although neither cytokine levels nor NF-jB
pathway activation was elevated in the hippocampus of post-
septic animals at 2 months post-treatment, microglia may also be
detrimental to neuronal function via mechanisms not measured
here such as the production of reactive oxygen species
(Hernandes et al., 2014), increased indoleamine 2,3-dioxygenase
production (Corona et al., 2013), altered chemokine expression
(Rivest, 2009) or changes in mitochondrial function (Noh et al.,
2014). Weberpals et al. (2009) did show in a very similar model
that there was a long-lasting alteration in brain metabolism, which
may in part impact on cognitive and behavioural processes. In
other studies a 5 mg/kg dose of LPS does not appear to induce
long-lasting neuronal loss, although pre- and post-synaptic protein
levels are altered in the hippocampus (Fan et al., 2012; Weberpals
et al., 2009) and we show that post-septic mice exhibit reduced
levels of IEG proteins essential to synaptic plasticity. The reduction
of NPCs produced in post-septic animals in this study may also
contribute to this pathology, although attenuating this may not
be critical to recover affective behaviour as exhibited.5. Conclusion
In conclusion, this study demonstrates that mice exhibit
increased depressive- and anxiety-like behaviours one month after
recovery from LPS-induced sepsis, with no long-lasting cognitive
impairment. These alterations in affective behaviour coincide with
a long lasting upregulation of microglial activation, altered IEG
expression and a reduction in the production of NPCs within the
hippocampus. Many of these changes are reversed by pre-treat-
ment with NF-jB inhibitor PDTC. Further work is necessary to
examine the effects of systemic LPS administration on other key
areas involved in affective behaviour (e.g. the amygdala), and the
survival, differentiation and incorporation of NPCs into hippocam-
pal networks. Further, the utility of pharmacological intervention
in reversing these effects after sepsis induction has occurred
should be examined, as should electrophysiological and neuroplas-
tic alterations which may occur in the post-septic brain. All of
these factors would allow for a better understanding of post-septic
encephalopathy with a view towards addressing the real clinical
needs of sepsis survivors.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.bbi.2014.07.007.
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